Status:
COMPLETED
An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery
Lead Sponsor:
OHSU Knight Cancer Institute
Conditions:
Head and Neck Carcinoma
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This clinical trial evaluates a prehabilitation exercise intervention for improving mobility and recovery outcomes in patients undergoing surgery for head and neck cancer. Prehabilitation focuses on o...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the impact of an exercise prehabilitation program on post-operative outcomes after head and neck cancer surgery. SECONDARY OBJECTIVE: I. To evaluate the impact of ...
Eligibility Criteria
Inclusion
- Older than 18 years of age and younger than 89 years of age. Both men and women and members of all races and ethnic groups may be included
- Planned to undergo major head and neck cancer surgery with free tissue transfer reconstruction at Oregon Health and Science University (OHSU) with the Department of Otolaryngology-Head and Neck Surgery with an expected length of stay (LOS) of 3 days or more
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Non-English speaking
- Planned postoperative admission to the intensive care unit (ICU)
- Social or psychiatric conditions that may interfere with compliance
- Further exclusion criteria may be applied due to conditions that may impact the ability to safely exercise as well as utilize the Fitbit devices:
- Symptoms of or ongoing work-up for unstable angina, uncontrolled tachyarrhythmias, decompensated heart failure, severe aortic stenosis, hypertrophic obstructive cardiomyopathy, uncontrolled hypertension (HTN), uncontrolled pulmonary HTN or uncontrolled asthma
- History of chest pain, dizziness or syncope with exercise
- Bony metastases to the spine or extremities
- Falls in the last year
- Cognitive impairments limiting safety or ability to use technology
- Impaired mobility requiring the use of assistive devices, such as use of a walker or wheelchair at baseline
- Isolation precautions, as they would not be allowed to ambulate on a patient floor post-operatively
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06079697
Start Date
February 1 2024
End Date
July 15 2025
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OHSU Knight Cancer Institute
Portland, Oregon, United States, 97239